世界卫生组织HEARTS高血压控制方案在孟加拉国的准实验评估
在孟加拉国农村7对匹配的Upazila健康综合体开展准实验试验,纳入3935例未控制高血压患者,比较实施WHO-HEARTS方案与常规照护的6个月结局。HEARTS组收缩压净多降3.7 mmHg、舒张压净多降1.9 mmHg,高血压控制率提高12.3%,失访率更低。
要点
- HEARTS方案使6个月收缩压较常规照护净降低3.7 mmHg(95%CI -5.1至-2.2)。
- HEARTS组高血压控制率62.0%,常规照护组49.7%,净差12.3%(95%CI 9.0至16.8)。
- HEARTS组错过就诊率8.8%,显著低于常规照护组的39.3%(p<0.001)。
核心结论
- 在孟加拉国农村实施WHO-HEARTS方案后,血压较常规照护显著降低且高血压控制率显著改善。
研究设计与样本
- 匹配对整群准实验试验,在孟加拉国农村的Upazila健康综合体(UHCs;初级卫生保健机构)开展。
- 共纳入3935例未控制高血压患者(平均年龄52.3岁,70.5%女性;血压≥140/90 mmHg regardless of treatment history),其中7个HEARTS UHCs 1950例,7个匹配的常规照护UHCs 1985例。
主要发现
- 基线平均收缩压干预组158.4 mmHg,常规照护组158.8 mmHg。
- 6个月时95.5%参与者完成随访;干预组收缩压降低23.7 mmHg vs 常规照护20.0 mmHg,净差-3.7 mmHg(95%CI -5.1至-2.2)。
- 舒张压降低10.2 mmHg vs 8.3 mmHg,净差-1.9 mmHg(95%CI -2.7至-1.1)。
- 高血压控制率(<140/90 mmHg)62.0% vs 49.7%,净差12.3%(95%CI 9.0至16.8)。
- 错过就诊率干预组8.8% vs 常规照护组39.3%(p<0.001)。
临床怎么用
- 在资源有限的初级卫生保健机构中,可考虑采用WHO-HEARTS技术包以改善高血压控制和减少失访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The World Health Organization (WHO) promotes the HEARTS technical package for improving hypertension control worldwide, but its effectiveness has not been rigorously evaluated. OBJECTIVE: To compare hypertension outcomes in clinics implementing HEARTS versus clinics continuing usual hypertension care in rural Bangladesh. METHODS: A matched-pair cluster quasi-experimental trial in Upazila Health Complexes (UHCs; primary healthcare facilities) was conducted in rural Bangladesh. A total of 3935 patients (mean age 52.3 years, 70.5% female) with uncontrolled hypertension (blood pressure (BP) ≥140/90 mm Hg regardless of treatment history) were enrolled: 1950 patients from 7 HEARTS UHCs and 1985 patients from 7 matched usual care UHCs. The primary outcome was systolic BP at 6 months measured at the patient's home; secondary outcomes were diastolic BP, hypertension control rate (<140/90 mm Hg) and loss to follow-up. Multivariable mixed-effects linear and Poisson models were conducted. RESULTS: Baseline mean systolic BP was 158.4 mm Hg in the intervention group and 158.8 mm Hg in the usual care group. At 6 months, 95.5% of participants completed follow-up. Compared with usual care, the intervention significantly lowered systolic BP (-23.7 mm Hg vs -20.0 mm Hg; net difference -3.7 mm Hg (95% CI -5.1 to -2.2)) and diastolic BP (-10.2 mm Hg vs -8.3 mm Hg; net difference -1.9 mm Hg (95% CI -2.7 to -1.1)) and improved hypertension control (62.0% vs 49.7%, net difference 12.3% (95% CI 9.0 to 16.8)). Rate of missed clinic visits was lower in the intervention group (8.8% vs 39.3%, p<0.001). CONCLUSIONS: After WHO-HEARTS package implementation in rural Bangladesh, BP was lowered and hypertension control improved significantly compared with usual care. TRIAL REGISTRATION NUMBER: NCT04992039.
引用
- Abrar A, Hu X, Akhtar J, et al. Evaluation of the World Health Organization-HEARTS hypertension control package in Bangladesh: a quasi-experimental trial. Heart. 2024. PMID: 39019496. doi:10.1136/heartjnl-2024-324253
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。